OCT 16·tradingview.comLow
QIAGEN N.V. (QIA) Discloses BlackRock 12.85% Voting Rights
QIAGEN disclosed that BlackRock holds 11.49% capital interest and 12.85% voting rights in the company as of October 14, 2026, according to a Dutch AFM filing.
StockNYSE · US · USDHealthcare · Diagnostics & Research
$QGEN
QIAGEN N.V.
AlphAI earnings readQ2 FY2026 · AUG 6QIAGEN exceeds Q2 2026 outlook as pillars deliver solid sales growth; reaffirms full-year outlookVerdict: solidRead →
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Price · $QGENvia TradingView
AI sentiment · 7d2 articles
- Bullish
- 1
- Neutral
- 1
- Bearish
- 0
Insider · 30dAll trades →
No SEC Form 4 filings for $QGEN in the last 30 days.
See all $QGEN insider activity →Top stories · $QGENMore →
OCT 16·tradingview.com
Release according to Article 40, Section 1 of the WpHG
Qiagen N.V. reported that BlackRock, Inc. made a voting rights notification to the AFM on October 16, 2026, regarding transactions dated October 14, 2026. The details were published in the AFM's register, and Qiagen N.V. is not responsible for the accuracy of the notification.
OCT 14·tradingview.com
QIAGEN N.V. (QIA) BlackRock Discloses 12.86% Voting Rights
QIAGEN received a notification from the Dutch AFM that BlackRock filed a disclosure on October 9, 2026, reporting an 11.50% capital interest and 12.86% voting rights in QIAGEN. The disclosure is routine and reflects BlackRock's passive and derivative exposure to the company.
QGEN sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning QGEN (QIAGEN N.V.). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.
Recent QGEN coverage spans financial news, regulation and market movers.
What's driving QGEN
QIAGEN disclosed that BlackRock holds 11.49% capital interest and 12.85% voting rights in the company as of October 14, 2026, according to a Dutch AFM filing.
The filing signals institutional interest which may support the stock price.
QIAGEN received a notification from the Dutch AFM that BlackRock filed a disclosure on October 9, 2026, reporting an 11.50% capital interest and 12.86% voting rights in QIAGEN. The disclosure is routine and reflects BlackRock's passive and derivative exposure to the company.
The disclosure may lead to modest selling pressure as the market evaluates BlackRock's influence.
Analyst target lift suggests modest upside pressure.
AlphAI scores every news story that mentions QGEN with an AI model for sentiment and relevance, and aggregates insider trades from QIAGEN N.V.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $QGEN
Score
QIAGEN N.V. (QIA) Discloses BlackRock 12.85% Voting Rights
QIAGEN disclosed that BlackRock holds 11.49% capital interest and 12.85% voting rights in the company as of October 14, 2026, according to a Dutch AFM filing.
1 min readRelease according to Article 40, Section 1 of the WpHG
Qiagen N.V. reported that BlackRock, Inc. made a voting rights notification to the AFM on October 16, 2026, regarding transactions dated October 14, 2026. The details were published in the AFM's register, and Qiagen N.V. is not responsible for the accuracy of the notification.
1 min readQIAGEN N.V. (QIA) BlackRock Discloses 12.86% Voting Rights
QIAGEN received a notification from the Dutch AFM that BlackRock filed a disclosure on October 9, 2026, reporting an 11.50% capital interest and 12.86% voting rights in QIAGEN. The disclosure is routine and reflects BlackRock's passive and derivative exposure to the company.
1 min readQIAGEN N.V. (QIA): BlackRock Discloses 12.91% Voting Rights
QIAGEN reported that BlackRock holds 11.54% capital interest and 12.91% voting rights in the company as of October 5, 2026, according to a Dutch AFM notification.
1 min readQiagen N.V. Stock 12‑Month Price Target Raised to $47.43, Implies 7% Upside
Qiagen N.V.'s average stock price target increased to $47.43 from $47.17, with a range of $40 to $55. This implies about 7% upside from the Oct. 8 closing price. The consensus rating remains 'Buy' among 20 analysts, with 9 Buys and 11 Holds.
1 min readQIAGEN N.V. (QIA): BlackRock Notifies 13.04% Voting Rights
QIAGEN N.V. reported that BlackRock, Inc. notified a 13.04% voting rights stake in the company, according to a Dutch AFM disclosure. The stake includes indirect holdings and potential instruments. This is a routine regulatory update, not a significant catalyst.
1 min read
S&P Set To Open At Record High As Oil Slides, Bond Rout Takes A Breather
US equity futures rose, with S&P 500 on track for a record open, led by tech. Nvidia nears $6T valuation. Constellation Energy (CEG) up 6.1% on Google nuclear deal. Option Care (OPCH) jumps 21% on potential acquisition. Oil prices fell, easing bond yields. AMD (AMD) up 2% on CEO's chip demand outlook. BorgWarner (BWA) gains 3.7% after Morgan Stanley upgrade. Global stocks rally on AI investment and strong earnings.
3 min readBarclays Upgrades QIAGEN to Overweight From Equalweight
Barclays upgraded QIAGEN (QGEN) to Overweight from Equalweight. The stock has a 5-day change of +2.32% and a year-to-date change of +1.73%. The upgrade is based on a weighted average of ratings including valuation, EPS revisions, and visibility.
1 min readQIAGEN N.V. (QIA): Bank of America Holds 4.95% Voting Rights
QIAGEN reported that Bank of America holds 4.95% of its voting rights and capital interest as of September 28, 2026, according to a Dutch AFM notification. The stake includes shares, options, and swaps.
1 min readQiagen gains on report talks with strategic buyer have advanced
Qiagen (QGEN) shares rose 7.3% on reports that talks with a US-listed molecular testing company have progressed, potentially leading to an acquisition at a 'realistic premium.'
1 min read